** Shares of Noxopharm NOX.AX rise nearly 46% to A$0.07, their biggest pct gain since October 4, 2023
** Stock hits highest level since June 6
** Biotech co says first dose of SOF-SKN, a drug candidate for autoimmune diseases was administered to trial participant
** Around 422,086 shares traded, 2.2x the 30-day avg
** YTD, shares down 24.7%, including today's move
(Reporting by Ananya Verma in Bengaluru)
((Ananya.Verma@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。